Immunomodulatory drugs (IMiDs) in multiple myeloma: mechanism of action and clinical implications
Immunomodulatory drugs (IMiDs) are a class of drugs, derived from the teratogenic compound thalidomide, that have made a major impact on treatment of many diseases, from multiple myeloma to assorted inflammatory diseases. From its dark beginnings as a teratogenic agent that caused phocomelia in newb...
| Main Author: | |
|---|---|
| Language: | en_US |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/24015 |